Tandem peptide receptor radionuclide therapy using (90)Y/(177)Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

INTRODUCTION: One of the concepts of theranostics in nuclear medicine is peptide receptor radionuclide therapy (PRRT), whereby labeled somatostatin analogs are used for imaging and treating inoperable or disseminated neuroendocrine tumors (NET). AIM: The aim of the study was to determine the therape...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur J Nucl Med Mol Imaging
Huvudupphovsmän: Kunikowska, Jolanta, Zemczak, Anna, Kołodziej, Maciej, Gut, Paweł, Łoń, Izabela, Pawlak, Dariusz, Mikołajczak, Renata, Kamiński, Grzegorz, Ruchała, Marek, Kos-Kudła, Beata, Królicki, Leszek
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2020
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7075861/
https://ncbi.nlm.nih.gov/pubmed/31980909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04690-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk